Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Raw Materials: 2019-2021

  • CureVac N.V's Raw Materials rose 290.74% to $64.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $64.2 million, marking a year-over-year increase of 290.74%. This contributed to the annual value of $64.2 million for FY2021, which is 290.74% up from last year.
  • CureVac N.V's Raw Materials amounted to $64.2 million in Q4 2021, which was up 290.74% from $16.4 million recorded in Q4 2020.
  • In the past 5 years, CureVac N.V's Raw Materials ranged from a high of $64.2 million in Q4 2021 and a low of $6.8 million during Q4 2019.
  • Moreover, its 3-year median value for Raw Materials was $16.4 million (2020), whereas its average is $29.2 million.
  • Data for CureVac N.V's Raw Materials shows a peak YoY surged of 290.74% (in 2021) over the last 5 years.
  • CureVac N.V's Raw Materials (Quarterly) stood at $6.8 million in 2019, then skyrocketed by 140.47% to $16.4 million in 2020, then surged by 290.74% to $64.2 million in 2021.
  • Its last three reported values are $64.2 million in Q4 2021, $16.4 million for Q4 2020, and $6.8 million during Q4 2019.